Kaneka agrees to supply active pharmaceutical ingredients for Avigan®Tablet
16th April 2020
Kaneka Corporation has reached an agreement with FUJIFILM Corporation to supply drug substances for anti-influenza drug, Avigan®Tablet (general name: favipiravir), for the novel coronavirus disease.
While COVID-19 continues to spread, the Japanese government has decided to increase its stockpiles of Avigan®Tablet, which is expected to be effective against COVID-19, for up to 2 million people, and FUJIFILM Corporation has expanded its production system and started increasing its production of Avigan®Tablet.
For more information visit www.kaneka.co.jp/en/service/news/nr20200416/
